229. Autoimmune pulmonary alveolar proteinosis Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 44 / Drugs : 22 - (DrugBank : 7) / Drug target genes : 3 - Drug target pathways : 14
Autoimmune pulmonary alveolar proteinosis and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 229 | Autoimmune pulmonary alveolar proteinosis |
| 6 | Parkinson disease |
| 46 | Malignant rheumatoid arthritis |
| 96 | Crohn disease |
| 97 | Ulcerative colitis |
| 94 | Primary sclerosing cholangitis |
| 285 | Fanconi anemia |
| 41 | Giant cell arteritis |
| 93 | Primary biliary cholangitis |
| 60 | Aplastic anemia |
| 222 | Primary nephrotic syndrome |
| 65 | Primary immunodeficiency |
| 299 | Cystic fibrosis |
| 86 | Pulmonary arterial hypertension |
| 49 | Systemic lupus erythematosus |
| 13 | Multiple sclerosis/Neuromyelitis optica |
| 52 | Mixed connective tissue disease |